Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
Avadel Pharmaceuticals SG&A Expense (Quarterly) : 52.64M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alkermes Plc | 171.77M |
| Medtronic Plc | 2.956B |
| STERIS Plc (Ireland) | 352.30M |
| Amarin Corp. Plc | 17.83M |
| Jazz Pharmaceuticals Plc | 530.65M |